Abstract: This special issue highlights emerging topics related to Candida, the most prevalent fungal pathogen in the hospital setting. The advantages and limitations of new, non-culture based diagnostic techniques are discussed. The issue reviews mammalian and non-mammalian infection models. The manuscripts present updates on several molecular mechanisms of pathogenicity, including filamentation, biofilm formation, and phospholipid production.
Galleria mellonella, and the free-living nematode Caenorhabditis elegans are described and compared to mammalian models.
The ability of Candida spp. to form biofilm communities on medical devices and biotic surfaces is an increasingly recognized virulence trait. In this issue, Kean and colleagues discuss biofilm formation by Candida, focusing on the current models of study. They review the molecular aspects underpinning the transition to the biofilm lifestyle and the acquisition of antifungal drug tolerance [9] . The authors highlight the inherent heterogeneity associated with these communities, which contain diverse microenvironments and form in distinct anatomic niches. Furthermore, the capacity to form biofilms varies greatly among Candida spp., as well as among clinical isolates of the same species. The importance of including a variety of clinical isolates for biofilm studies is also discussed.
Two manuscripts in this issue provide updates on our understanding of hyphal morphogenesis. Components of this pathway are potential drug targets, as filamentation is unique to fungi and critical for the pathogenesis of C. albicans. The review by Desai divides the formation of hyphae into 3 steps, which include hyphal initiation, elongation, and directionality maintenance [10] . The mechanistic regulation of each step is discussed, as are the environmental cues triggering filamentation. The concepts of both fungal-mediated tissue invasion and host-assisted uptake are reviewed. Lin and Chen also provide an update on the signaling pathways governing morphogenesis in Candidia [11] . Their review focuses on the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) cascade, which regulates hyphal growth as well as white-opaque switching in C. albicans. Similarities and differences in these regulatory pathways between C. albicans and its close relative C. tropicalis are highlighted. Identifying signaling components conserved among Candida spp., and even among fungi, is essential for recognizing potential broad-spectrum drug targets.
This issue also features a review of phospholipid biosynthesis in C. albicans, focusing on two aminophospholipids, phosphatidylserine and phosphatidylethanolamine, and their role in microbial pathogenesis [12] . Cassilly and Reynolds describe the current knowledge of the phosphatidylserine and phosphatidylethanolamine synthesis pathways in C. albicans and provide a comparison to these biosynthetic pathways in other eukaryotes, as well as bacteria. The potential for targeting aminophospholipid pathways for drug development is discussed. In particular, the phosphatidylserine synthase of C. albicans appears to be conserved among fungi and is structurally distinct from mammalian phospholipid synthases.
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